Fulvimac Injection
Marketer
Admac Pharma Ltd
Salt Composition
Fulvestrant (250mg/5ml)
Overview Fulvimac Injection
Estroblock, administered via intramuscular injection, counteracts estrogen activity. Indicated for postmenopausal women with breast cancer, it mitigates estrogen levels to inhibit tumor growth. Administered by a physician, the dosage and frequency are individualized based on the patient's condition and response. Treatment duration aligns with the prescribed regimen. Common adverse effects encompass injection site reactions, headache, nausea, vomiting, and allergic responses. Significant or persistent side effects warrant immediate medical attention; management strategies may be available. Prior to initiating therapy, disclose any history of hepatic or renal impairment, bleeding disorders, anticoagulant use, or concurrent medications. Furthermore, inform your physician of pregnancy, pregnancy intentions, or breastfeeding.
Uses of Fulvimac Injection
Malignancy of the mammary gland
Major Benefits of Fulvimac Injection:
This medication will be administered by your physician or their qualified assistant. Self-medication is strictly prohibited.
Common Side effects of Fulvimac Injection:
- Headache
- Vomiting
- Weakness
- Allergic reaction
- Nausea
- Injection site reaction
- Urinary tract infection
- Diarrhea
How to use Fulvimac Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Fulvimac Injection works:
Fulvimac Injection inhibits estrogen's effects on breast cancer cells, potentially reducing or halting the proliferation of estrogen-dependent breast tumors.
SAFETY ADVICE
AlcoholCAUTION
Use of Fulvimac Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Fulvimac Injection during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Administering Fulvimac Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingSAFE
Operating a vehicle is typically unaffected by Fulvimac Injection.
KidneyCAUTION
Exercise caution when administering Fulvimac Injection to individuals with severe kidney impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Fulvimac Injection use in such patients is limited. Dosage alterations are not advised for those with mild to moderate kidney dysfunction.
LiverCAUTION
Patients with hepatic impairment should receive Fulvimac Injection with careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Fulvimac Injection :
Should you forget a scheduled Fulvimac Injection, seek your physician's advice.
Facts to Know About Fulvimac Injection
| Label | Value |
|---|---|
| Type of Compound | Estrogen-based medications |
| Potential for Dependence | None. |
| Medication Classification | Cancer-fighting drugs |
| Mechanism of Action | Substance blocking estrogen receptors |



